Pathology and molecular biology of gastric cancer

Best Practice and Research: Clinical Gastroenterology

Volumn 20, Issue 4, 2006, Pages 651-674

  Vauhkonen, Matti ^a   Vauhkonen, Hanna ^b   Sipponen, Pentti ^c  

^a JORVI HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

classification; gastric carcinoma; histopathology; molecular pathology

Indexed keywords

DNA; PROTEIN P53; UVOMORULIN;

ACHLORHYDRIA; ADENOMA; ARTICLE; ATROPHIC GASTRITIS; CANCER CLASSIFICATION; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CHROMOSOME ABERRATION; DYSPLASIA; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC EPIGENESIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; INTESTINE METAPLASIA; MICROMORPHOLOGY; MICROSATELLITE INSTABILITY; MOLECULAR BIOLOGY; NONHUMAN; PATHOGENESIS; PATHOLOGY; PRECANCER; PREDICTION; PROMOTER REGION; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; STOMACH MUCOSA LESION;

DISEASE PROGRESSION; DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MUTATION; NEOPLASM STAGING; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33748870978     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2006.03.016     Document Type: Article

References (150)

1. Schistosomes, liver flukes and Helicobacter pylori. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans vol. 6 (1994), IARC, Lyon pp. 177-220
2. Jass J.R., Sobin L.H., and Watanabe H. The World Health Organization's histologic classification of gastrointestinal tumors. A commentary on the second edition. Cancer 66 (1990) 2162-2167
3. Ming S.C. Gastric carcinoma. A pathobiological classification. Cancer 39 (1977) 2475-2485
4. Mulligan R.M. Histogenesis and biologic behavior of gastric carcinoma. Pathol Annu 7 (1972) 349-415
5. Laurén P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal type carcinoma. Acta Pathol Microbiol Scand 64 (1965) 31-49
6. Goseki N., Takizawa T., and Koike M. Differences in the mode of the extension of gastric cancer classified by histological type: new histological classification of gastric carcinoma. Gut 33 (1992) 606-612
7. Borchard F. Classification of gastric carcinoma. Hepatogastroenterology 37 (1990) 223-232
8. Songun I., van de Velde C.J., Arends J.W., et al. Classification of gastric carcinoma using the Goseki system provides prognostic information additional to TNM staging. Cancer 85 (1999) 2114-2118
9. Siurala M., Varis K., and Sipponen P. Carcinogenesis in the foregut. Part 2. Gastric carcinoma. In: Baron J.H., and Moody F.G. (Eds). Foregut (1981), Butterworths, London 276-312
10. Sipponen P., Price A., Kekki M., et al. Gastritis. In: Gustavsson, Kumar D., and Graham D. (Eds). The Stomach (1992), Churchill Livingstone, Edinburgh 313-340
11. Carneiro F., Seixas M., and Sobrinho-Simoes M. New elements for an updated classification of the carcinomas of the stomach. Pathol Res Pract 191 (1995) 571-584
12. Grundmann E., and Schlake W. Histological classification of gastric cancer from initial to advanced stages. Pathol Res Pract 173 (1982) 260-274
13. Sipponen P., Kekki M., Haapakoski J., et al. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer 35 (1985) 173-177
14. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 52 (1992) 6735-6740
15. Sipponen P., and Correa P. Delayed rise in incidence of gastric cancer in females results in unique sex ratio (M/F) pattern: etiologic hypothesis. Gastric Cancer 5 (2002) 213-219
16. Ming S.C. Cellular and molecular pathology of gastric carcinoma and precursor lesions: a critical review. Gastric Cancer 1 (1998) 31-50
17. Werner M., Becker K.F., Keller G., et al. Gastric adenocarcinoma: pathomorphology and molecular pathology. J Cancer Res Clin Oncol 127 (2001) 207-216
18. Fiocca R., Luinetti O., Villani L., et al. Molecular mechanisms involved in the pathogenesis of gastric carcinoma: interactions between genetic alterations, cellular phenotype and cancer histotype. Hepatogastroenterology 48 (2001) 1523-1530
19. Tahara E. Genetic pathways of two types of gastric cancer. IARC Sci Publ 157 (2004) 327-349
20. Gologan A., Graham D.Y., and Sepulveda A.R. Molecular markers in Helicobacter pylori-associated gastric carcinogenesis. Clin Lab Med 25 (2005) 197-222
21. Zheng L., Wang L., Ajani J., et al. Molecular basis of gastric cancer development and progression. Gastric Cancer 7 (2004) 61-67
22. Sipponen P., Kekki M., and Siurala M. Age-related trends of gastritis and intestinal metaplasia in gastric carcinoma patients and in controls representing the population at large. Br J Cancer 49 (1984) 521-530
23. Sipponen P., and Marshall B.J. Gastritis and gastric cancer in Western countries. Gastroenterol Clin North Am 29 (2000) 579-592
24. Fitzgerald R.C., and Caldas C. Clinical implications of E-cadherin associated hereditary diffuse gastric cancer. Gut 53 (2004) 775-778
25. Keller G., Vogelsang H., Becker I., et al. Germline mutations of the E-cadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients. J Med Genet 41 (2004) e89
26. Guilford P., Hopkins J., Harraway J., et al. E-cadherin germline mutations in familial gastric cancer. Nature 392 (1998) 402-405
27. Oliveira C., Bordin M.C., Grehan N., et al. Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred. Hum Mutat 19 (2002) 510-517
28. Kim I.J., Park J.H., Kang H.C., et al. A novel germline mutation in the MET extracellular domain in a Korean patient with the diffuse type of familial gastric cancer. J Med Genet 40 (2003) e97
29. Hasegawa S., Furukawa Y., Li M., et al. Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23,040 genes. Cancer Res 62 (2002) 7012-7017
30. Boussioutas A., Li H., Liu J., et al. Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancer. Cancer Res 63 (2003) 2569-2577
31. Hippo Y., Taniguchi H., Tsutsumi S., et al. Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res 62 (2002) 233-240
32. Lee S., Baek M., Yang H., et al. Identification of genes differentially expressed between gastric cancers and normal gastric mucosa with cDNA microarrays. Cancer Lett 184 (2002) 197-206
33. Solcia E., Fiocca R., Luinetti O., et al. Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement. Am J Surg Pathol 20 supplement 1 (1996) S8-S22
34. Wu M.S., Shun C.T., Sheu J.C., et al. Overexpression of mutant p53 and c-erbB-2 proteins and mutations of the p15 and p16 genes in human gastric carcinoma: with respect to histological subtypes and stages. J Gastroenterol Hepatol 13 (1998) 305-310
35. Fenoglio-Preiser C.M., Wang J., Stemmermann G.N., et al. TP53 and gastric carcinoma: a review. Hum Mutat 21 (2003) 258-270
36. Ranzani G.N., Renault B., Pellegata N.S., et al. Loss of heterozygosity and K-ras gene mutations in gastric cancer. Hum Genet 92 (1993) 244-249
37. Lee K.H., Lee J.S., Suh C., et al. Clinicopathologic significance of the K-ras gene codon 12 point mutation in stomach cancer. An analysis of 140 cases. Cancer 75 (1995) 2794-2801
38. Hiyama T., Haruma K., Kitadai Y., et al. K-ras mutation in Helicobacter pylori-associated chronic gastritis in patients with and without gastric cancer. Int J Cancer 97 (2002) 562-566
39. Yashiro M., Nishioka N., and Hirakawa K. K-ras mutation influences macroscopic features of gastric carcinoma. J Surg Res 124 (2005) 74-78
40. Park T.J., Han S.U., Cho Y.K., et al. Methylation of O(6)-methylguanine-DNA methyltransferase gene is associated significantly with K-ras mutation, lymph node invasion, tumor staging, and disease free survival in patients with gastric carcinoma. Cancer 92 (2001) 2760-2768
41. Esteller M., and Herman J.G. Generating mutations but providing chemosensitivity: the role of O6-methylguanine DNA methyltransferase in human cancer. Oncogene 23 (2004) 1-8
42. Horii A., Nakatsuru S., Miyoshi Y., et al. The APC gene, responsible for familial adenomatous polyposis, is mutated in human gastric cancer. Cancer Res 52 (1992) 3231-3233
43. Ebert M.P., Fei G., Kahmann S., et al. Increased beta-catenin mRNA levels and mutational alterations of the APC and beta-catenin gene are present in intestinal-type gastric cancer. Carcinogenesis 23 (2002) 87-91
44. Lee J.H., Abraham S.C., Kim H.S., et al. Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma. Am J Pathol 161 (2002) 611-618
45. Wang J.Y., Hsieh J.S., Chen C.C., et al. Alterations of APC, c-met, and p53 genes in tumor tissue and serum of patients with gastric cancers. J Surg Res 120 (2004) 242-248
46. Becker K.F., Atkinson M.J., Reich U., et al. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 54 (1994) 3845-3852
47. Machado J.C., Oliveira C., Carvalho R., et al. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene 20 (2001) 525-528
48. Ascaño J.J., Frierson Jr. H., Moskaluk C.A., et al. Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer. Mod Pathol 14 (2001) 942-949
49. Park W.S., Oh R.R., Park J.Y., et al. Somatic mutations of the trefoil factor family 1 gene in gastric cancer. Gastroenterology 119 (2000) 691-698
50. Carvalho R., Kayademir T., Soares P., et al. Loss of heterozygosity and promoter methylation, but not mutation, may underlie loss of TFF1 in gastric carcinoma. Lab Invest 82 (2002) 1319-1326
51. Park W.S., Oh R.R., Park J.Y., et al. Frequent somatic mutations of the beta-catenin gene in intestinal-type gastric cancer. Cancer Res 59 (1999) 4257-4260
52. Kallioniemi A., Kallioniemi O.P., Sudar D., et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258 (1992) 818-821
53. Pinkel D., Segraves R., Sudar D., et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 20 (1998) 207-211
54. Yokota J., Yamamoto T., Miyajima N., et al. Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue. Oncogene 2 (1988) 283-287
55. Kameda T., Yasui W., Yoshida K., et al. Expression of ERBB2 in human gastric carcinomas: relationship between p185ERBB2 expression and the gene amplification. Cancer Res 50 (1990) 8002-8009
56. Hattori Y., Itoh H., Uchino S., et al. Immunohistochemical detection of K-sam protein in stomach cancer. Clin Cancer Res 2 (1996) 1373-1381
57. Hattori Y., Odagiri H., Nakatani H., et al. K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes. Proc Natl Acad Sci U S A 87 (1990) 5983-5987
58. Wu M.S., Shun C.T., Wang H.P., et al. Genetic alterations in gastric cancer: relation to histological subtypes, tumor stage, and Helicobacter pylori infection. Gastroenterology 112 (1997) 1457-1465
59. Kokkola A., Monni O., Puolakkainen P., et al. 17q12-21 amplicon, a novel recurrent genetic change in intestinal type of gastric carcinoma: a comparative genomic hybridization study. Genes Chromosomes Cancer 20 (1997) 38-43
60. Wu M.S., Chang M.C., Huang S.P., et al. Correlation of histologic subtypes and replication error phenotype with comparative genomic hybridization in gastric cancer. Genes Chromosomes Cancer 30 (2001) 80-86
61. Koo S.H., Kwon K.C., Shin S.Y., et al. Genetic alterations of gastric cancer: comparative genomic hybridization and fluorescence in situ hybridization studies. Cancer Genet Cytogenet 117 (2000) 97-103
62. Peng D.F., Sugihara H., Mukaisho K.I., et al. Alterations of chromosomal copy number during progression of diffuse-type gastric carcinomas: metaphase- and array-based comparative genomic hybridization analyses of multiple samples from individual tumours. J Pathol 201 (2003) 439-450
63. van Grieken N.C., Weiss M.M., Meijer G.A., et al. Helicobacter pylori-related and -non-related gastric cancers do not differ with respect to chromosomal aberrations. J Pathol 192 (2000) 301-306
64. Noguchi T., Wirtz H.C., Michaelis S., et al. Chromosomal imbalances in gastric cancer. Correlation with histologic subtypes and tumor progression. Am J Clin Pathol 115 (2001) 828-884
65. Nessling M., Solinas-Toldo S., Wilgenbus K.K., et al. Mapping of chromosomal imbalances in gastric adenocarcinoma revealed amplified protooncogenes MYCN, MET, WNT2, and ERBB2. Genes Chromosomes Cancer 23 (1998) 307-316
66. Choi S.W., Choi J.R., Chung Y.J., et al. Prognostic implications of microsatellite genotypes in gastric carcinoma. Int J Cancer 89 (2000) 378-383
67. Keller G., Rotter M., Vogelsang H., et al. Microsatellite instability in adenocarcinomas of the upper gastrointestinal tract. Relation to clinicopathological data and family history. Am J Pathol 147 (1995) 593-600
68. Seruca R., Santos N.R., David L., et al. Sporadic gastric carcinomas with microsatellite instability display a particular clinicopathologic profile. Int J Cancer 64 (1995) 32-36
69. Halling K.C., Harper J., Moskaluk C.A., et al. Origin of microsatellite instability in gastric cancer. Am J Pathol 155 (1999) 205-211
70. Sepulveda A.R., Santos A.C., Yamaoka Y., et al. Marked differences in the frequency of microsatellite instability in gastric cancer from different countries. Am J Gastroenterol 94 (1999) 3034-3038
71. Fang D.C., Jass J.R., Wang D.X., et al. Infrequent loss of heterozygosity of APC/MCC and DCC genes in gastric cancer showing DNA microsatellite instability. J Clin Pathol 52 (1999) 504-508
72. Vauhkonen M, Vauhkonen H, Sajantila A et al. Intestinal and diffuse type of gastric cancer represent different genetic integrity as assessed with non-cancer related tetranucleotide microsatellite markers. Gastric Cancer 2005; 8: 238-244.
73. Buonsanti G., Calistri D., Padovan L., et al. Microsatellite instability in intestinal- and diffuse-type gastric carcinoma. J Pathol 182 (1997) 167-173
74. Leung S.Y., Yuen S.T., Chung L.P., et al. hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res 59 (1999) 159-164
75. Fleischer A.S., Esteller M., Wang S., et al. Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res 59 (1999) 1090-1095
76. Pinto M., Oliveira C., Machado J.C., et al. MSI-L gastric carcinomas share the hMLH1 methylation status of MSI-H carcinomas but not their clinicopathological profile. Lab Invest 80 (2000) 1915-1923
77. Wu M.S., Lee C.W., Shun C.T., et al. Clinicopathological significance of altered loci of replication error and microsatellite instability-associated mutations in gastric cancer. Cancer Res 58 (1998) 1494-1497
78. Kim J.J., Baek M.J., Kim L., et al. Accumulated frameshift mutations at coding nucleotide repeats during the progression of gastric carcinoma with microsatellite instability. Lab Invest 79 (1999) 1113-1120
79. Kim H.S., Woo D.K., Bae S.I., et al. Microsatellite instability in the adenoma-carcinoma sequence of the stomach. Lab Invest 80 (2000) 57-64
80. Lee H.S., Choi S.I., Lee H.K., et al. Distinct clinical features and outcomes of gastric cancers with microsatellite instability. Mod Pathol 15 (2002) 632-640
81. Mori Y., Sato F., Selaru F.M., et al. Instabilotyping reveals unique mutational spectra in microsatellite-unstable gastric cancers. Cancer Res 62 (2002) 3641-6345
82. Lengauer C., Kinzler K.W., and Vogelstein B. Genetic instabilities in human cancers. Nature 396 (1998) 643-649
83. Tomlinson I.P.M., Roylance R., and Houlston R.S. Two hits revisited again. J Med Genet 38 (2001) 81-85
84. Thiagalingam S., Foy R.L., Cheng K.H., et al. Loss of heterozygosity as a predictor to map tumor suppressor genes in cancer: molecular basis of its occurrence. Curr Opin Oncol 14 (2002) 65-72
85. Tamura G., Sakata K., Nishizuka S., et al. Allelotype of adenoma and differentiated adenocarcinoma of the stomach. J Pathol 180 (1996) 371-377
86. Kim K.M., Kwon M.S., Hong S.J., et al. Genetic classification of intestinal-type and diffuse-type gastric cancers based on chromosomal loss and microsatellite instability. Virchows Arch 443 (2003) 491-500
87. Nishizuka S., Tamura G., Terashima M., et al. Loss of heterozygosity during the development and progression of differentiated adenocarcinoma of the stomach. J Pathol 185 (1998) 38-43
88. McKie A.B., Filipe M.I., and Lemoine N.R. Abnormalities affecting the APC and MCC tumour suppressor gene loci on chromosome 5q occur frequently in gastric cancer but not in pancreatic cancer. Int J Cancer 55 (1993) 598-603
89. Tamura G., Sato K., Akiyama S., et al. Molecular characterization of undifferentiated-type gastric carcinoma. Lab Invest 81 (2001) 593-598
90. Carvalho R., Milne A.N., van Rees B.P., et al. Early-onset gastric carcinomas display molecular characteristics distinct from gastric carcinomas occurring at a later age. J Pathol 204 (2004) 75-83
91. Toyota M., Ahuja N., Suzuki H., et al. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res 59 (1999) 5438-5442
92. Oue N., Oshimo Y., Nakayama H., et al. DNA methylation of multiple genes in gastric carcinoma: association with histological type and CpG island methylator phenotype. Cancer Sci 94 (2003) 901-905
93. Carvalho B., Pinto M., Cirnes L., et al. Concurrent hypermethylation of gene promoters is associated with a MSI-H phenotype and diploidy in gastric carcinomas. Eur J Cancer 39 (2003) 1222-1227
94. An C., Choi I.S., Yao J.C., et al. Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma. Clin Cancer Res 11 (2005) 656-663
95. Bird A.P. CpG-rich islands and the function of DNA methylation. Nature 321 (1986) 209-213
96. Esteller M., and Herman J.G. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol 196 (2002) 1-7
97. Herman J.G., and Baylin S.B. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349 (2003) 2042-2054
98. Guilleret I., Yan P., Grange F., et al. Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity. Int J Cancer 10 (2002) 335-341
99. Wu M.S., Wang H.P., Lin C.C., et al. Loss of imprinting and over-expression of IGF2 gene in gastric adenocarcinoma. Cancer Lett 120 (1997) 9-14
100. Akiyama Y., Maesawa C., Ogasawara S., et al. Cell-type-specific repression of the Maspin gene is disrupted frequently by demethylation at the promoter region in gastric intestinal metaplasia and cancer cells. Am J Pathol 163 (2003) 1911-1919
101. Oshimo Y., Nakayama H., Ito R., et al. Promoter methylation of cyclin D2 gene in gastric carcinoma. Int J Oncol 23 (2003) 1663-1670
102. Hamai Y., Oue N., Mitani Y., et al. DNA hypermethylation and histone hypoacetylation of the HLTF gene are associated with reduced expression in gastric carcinoma. Cancer Sci 94 (2003) 692-698
103. Yasui W., Oue N., Ono S., et al. Histone acetylation and gastrointestinal carcinogenesis. Ann N Y Acad Sci 983 (2003) 220-231
104. Esteller M. Aberrant DNA methylation as a cancer-inducing mechanism. Annu Rev Pharmacol Toxicol 45 (2005) 629-656
105. Hong S.H., Kim H.G., Chung W.B., et al. DNA hypermethylation of tumor-related genes in gastric carcinoma. J Korean Med Sci 20 (2005) 236-241
106. Esteller M., Corn P.G., Baylin S.B., et al. A gene hypermethylation profile of human cancer. Cancer Res 61 (2001) 3225-3229
107. Tamura G., Yin J., Wang S., et al. E-cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst 92 (2000) 569-573
108. Waki T., Tamura G., Tsuchiya T., et al. Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia. Am J Pathol 161 (2002) 399-403
109. Chan A.O., Lam S.K., Wong B.C., et al. Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut 52 (2003) 502-506
110. Oue N., Shigeishi H., Kuniyasu H., et al. Promoter hypermethylation of MGMT is associated with protein loss in gastric carcinoma. Int J Cancer 93 (2001) 805-809
111. Iida S., Akiyama Y., Nakajima T., et al. Alterations and hypermethylation of the p14(ARF) gene in gastric cancer. Int J Cancer 87 (2000) 654-658
112. Kaneda A., Kaminishi M., Yanagihara K., et al. Identification of silencing of nine genes in human gastric cancers. Cancer Res 62 (2002) 6645-6650
113. Waki T., Tamura G., Sato M., et al. Promoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epithelia. Cancer Sci 94 (2003) 360-364
114. Beck F. The role of Cdx genes in the mammalian gut. Gut 53 (2004) 1394-1396
115. Silberg D.G., Furth E.E., Taylor J.K., et al. CDX1 protein expression in normal, metaplastic, and neoplastic human alimentary tract epithelium. Gastroenterology 113 (1997) 478-486
116. Yuasa Y. Control of gut differentiation and intestinal-type gastric carcinogenesis. Nat Rev Cancer 3 (2003) 592-600
117. Mutoh H., Sakurai S., Satoh K., et al. Cdx1 induced intestinal metaplasia in the transgenic mouse stomach: comparative study with Cdx2 transgenic mice. Gut 53 (2004) 1416-1423
118. Bai Y.Q., Yamamoto H., Akiyama Y., et al. Ectopic expression of homeodomain protein CDX2 in intestinal metaplasia and carcinomas of the stomach. Cancer Lett 176 (2002) 47-55
119. Mizoshita T., Inada K., Tsukamoto T., et al. Expression of Cdx1 and Cdx2 mRNAs and relevance of this expression to differentiation in human gastrointestinal mucosa - with special emphasis on participation in intestinal metaplasia of the human stomach. Gastric Cancer 4 (2001) 185-191
120. Almeida R., Silva E., Santos-Silva F., et al. Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas. J Pathol 199 (2003) 36-40
121. Paik C.H., Han D.S., Lee S.H., et al. Expression of Cdx-2 homeobox gene in intestinal metaplasia and gastric adenocarcinoma. Korean J Gastroenterol 44 (2004) 186-192
122. Sung J.J., Leung W.K., Go M.Y., et al. Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions. Am J Pathol 157 (2000) 729-735
123. Filipe M.I., Osborn M., Linehan J., et al. Expression of transforming growth factor alpha, epidermal growth factor receptor and epidermal growth factor in precursor lesions to gastric carcinoma. Br J Cancer 71 (1995) 30-36
124. Sun Y., Li J.Y., He J.S., et al. Tissue microarray analysis of multiple gene expression in intestinal metaplasia, dysplasia and carcinoma of the stomach. Histopathology 46 (2005) 505-514
125. Tatematsu M., Tsukamoto T., and Inada K. Stem cells and gastric cancer: role of gastric and intestinal mixed intestinal metaplasia. Cancer Sci 94 (2003) 135-141
126. Osaki M., Moriyama M., Adachi K., et al. Expression of RUNX3 protein in human gastric mucosa, intestinal metaplasia and carcinoma. Eur J Clin Invest 34 (2004) 605-612
127. Suzuki K., Kashimura H., Ohkawa J., et al. Expression of human telomerase catalytic subunit gene in cancerous and precancerous gastric conditions. J Gastroenterol Hepatol 15 (2000) 744-751
128. Jong H.S., Park Y.I., Kim S., et al. Up-regulation of human telomerase catalytic subunit during gastric carcinogenesis. Cancer 86 (1999) 559-565
129. Yao X.X., Yin L., and Sun Z.C. The expression of hTERT mRNA and cellular immunity in gastric cancer and precancerosis. World J Gastroenterol 8 (2002) 586-590
130. Maesawa C., Tamura G., Suzuki Y., et al. The sequential accumulation of genetic alterations characteristic of the colorectal adenoma-carcinoma sequence does not occur between gastric adenoma and adenocarcinoma. J Pathol 176 (1995) 249-258
131. Isogaki J., Shinmura K., Yin W., et al. Microsatellite instability and K-ras mutations in gastric adenomas, with reference to associated gastric cancers. Cancer Detect Prev 3 (1999) 204-214
132. Kokkola A., Monni O., Puolakkainen P., et al. Presence of high-level DNA copy number gains in gastric carcinoma and severely dysplastic adenomas but not in moderately dysplastic adenomas. Cancer Genet Cytogenet 107 (1998) 32-36
133. Weiss M.M., Kuipers E.J., Postma C., et al. Genome wide array comparative genomic hybridisation analysis of premalignant lesions of the stomach. Mol Pathol 56 (2003) 293-298
134. Kim Y.H., Kim N.G., Lim J.G., et al. Chromosomal alterations in paired gastric adenomas and carcinomas. Am J Pathol 158 (2001) 655-662
135. Kashiwagi K., Watanabe M., Ezaki T., et al. Clinical usefulness of microsatellite instability for the prediction of gastric adenoma or adenocarcinoma in patients with chronic gastritis. Br J Cancer 82 (2000) 1814-1818
136. Leung W.K., Kim J.J., Kim J.G., et al. Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer. Am J Pathol 156 (2000) 537-543
137. Semba S., Yokozaki H., Yamamoto S., et al. Microsatellite instability in precancerous lesions and adenocarcinomas of the stomach. Cancer 77 supplement 8 (1996) 1620-1627
138. Baek M.J., Kang H., Kim S.E., et al. Expression of hMLH1 is inactivated in the gastric adenomas with enhanced microsatellite instability. Br J Cancer 85 (2001) 1147-1152
139. Lee J.H., Park S.J., Abraham S.C., et al. Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas. Oncogene 23 (2004) 646-654
140. Moragoda L., Jaszewski R., Kulkarni P., et al. Age-associated loss of heterozygosity of tumor suppressor genes in the gastric mucosa of humans. Am J Physiol Gastrointest Liver Physiol 282 (2002) G932-G936
141. Waki T., Tamura G., Sato M., et al. Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samples. Oncogene 22 (2003) 4128-4133
142. Kang G.H., Shim Y.H., Jung H.Y., et al. CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res 61 (2001) 2847-2851
143. Kang G.H., Lee S., Kim J.S., et al. Profile of aberrant CpG island methylation along the multistep pathway of gastric carcinogenesis. Lab Invest 83 (2003) 635-641
144. To K.F., Leung W.K., Lee T.L., et al. Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer. Int J Cancer 10 (2002) 623-628
145. Kim T.Y., Jong H.S., Jung Y., et al. DNA hypermethylation in gastric cancer. Aliment Pharmacol Ther 20 supplement 1 (2004) 131-142
146. Choi I.S., and Wu T.T. Epigenetic alterations in gastric carcinogenesis. Cell Res 15 (2005) 247-524
147. Kang G.H., Lee H.J., Hwang K.S., et al. Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. Am J Pathol 163 (2003) 1551-1556
148. Sun Y., Deng D., You W.C., et al. Methylation of p16 CpG islands associated with malignant transformation of gastric dysplasia in a population-based study. Clin Cancer Res 10 (2004) 5087-5093
149. Kubicka S., Claas C., Staab S., et al. p53 Mutation pattern and expression of c-erbB2 and c-met in gastric cancer: relation to histological subtypes, Helicobacter pylori infection, and prognosis. Dig Dis Sci 47 (2002) 114-121
150. Leung W.K., and Sung J.J. Pathogenesis of pre-neoplastic lesions of the stomach: targets for prevention. Dig Dis 22 (2004) 306-312